≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_LEIOMYOSARCOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C48.3|C49.3|C5421
  • Cause of death: ICD-10 — C48.3|C49.3|C5421
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 8890
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

314

4. Check minimum number of events

None

314

5. Include endpoints

None

314

6. Filter based on genotype QC (FinnGen only)

314

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Leiomyosarcoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 314 212 102
Unadjusted period prevalence (%) 0.06 0.07 0.04
Median age at first event (years) 60.36 58.51 64.23

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
218
Matched controls
2180
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
182.3
81.6
81
7
130
Kela drug reimbursment
Malignant tumour
+∞
75.5
68
*
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
74.3
67
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
622.8
51.7
49
*
A03FA01
ATC
metoclopramide; systemic, rectal
12.1
48.7
101
145
128
Kela drug reimbursment
Cancers of female genital organs
+∞
47.7
44
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
47.7
44
*
JN4BD
NOMESCO Finland
Extensive body CT
20.1
45.6
71
51
A04AA01
ATC
ondansetron; systemic, rectal
44.3
44.2
54
16
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
43.2
40
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
40.9
38
*
8890/3-C54.9
ICD-O-3
Leiomyosarcoma, NOS, of corpus uteri
+∞
40.9
38
*
JN4AD
NOMESCO Finland
Body CT examination
27.8
36.5
50
23
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
78.6
35.3
39
6
8890/3-C49.2
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
34.3
32
*
N02AA05
ATC
oxycodone; systemic
8.8
33.9
82
140
A04AA02
ATC
granisetron; systemic, transdermal
390.5
33.9
33
*
Z51.5
ICD-10 Finland
Palliative care
24.6
33.1
47
24
C49.23
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip leiomyosarcoma
+∞
32.1
30
*
L03AA02
ATC
filgrastim; parenteral
+∞
32.1
30
*
B01AB10
ATC
tinzaparin; parenteral
16.7
31.8
52
40
XX3DW
NOMESCO Finland
Time consuming IT work
15.9
31.1
52
42
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
31.0
29
*
8890/3-C54.2
ICD-O-3
Leiomyosarcoma, NOS, of myometrium
+∞
31.0
29
*
159
Kela drug reimbursment
Pazopanib
+∞
27.7
26
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
27.7
26
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
26.6
25
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
26.6
25
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
25.5
24
*
C54.2
ICD-10 Finland
Malignant neoplasm: Myometrium
+∞
25.5
24
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
26.6
24.8
34
15
C48.03
ICD-10 Finland
Malignant tumor of the retroperitoneal space leiomyosarcoma
+∞
24.4
23
*
L02BG04
ATC
letrozole; oral
140.4
24.1
25
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.9
24.0
101
328
WX302
NOMESCO Finland
Thoracal epidural anesthesy
16.1
23.9
39
29
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
23.3
22
*
B01AB05
ATC
enoxaparin; parenteral
4.5
22.9
110
403
A04AD12
ATC
aprepitant; systemic
+∞
22.3
21
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
24.6
21.5
30
14
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
21.2
20
*
L01XE11
ATC
[U] pazopanib; oral
+∞
21.2
20
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
11.1
20.7
40
43
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
219.0
19.9
20
*
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
17.2
19.1
30
20
D70.82
ICD-10 Finland
Drug-induced neutropenia
57.7
18.3
21
*
JN4CD
NOMESCO Finland
Very extensive body CT
29.7
18.2
24
9
WZC30
NOMESCO Finland
Teaching
6.2
17.4
50
100
8890/3-C49.1
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
16.9
16
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
16.9
16
*
C49.43
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen leiomyosarcoma
+∞
16.9
16
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
183.4
16.7
17
*
LCD00
NOMESCO Finland
Hysterectomy
8.0
16.4
38
56
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.8
15
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
15.8
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.8
15.6
81
295
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
12.7
15.3
27
24
WW500
NOMESCO Finland
Blood transfusion
18.2
15.1
23
14
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
34.5
15.1
19
6
ZZR00
NOMESCO Finland
Flap of skin
86.0
14.8
16
*
C49.13
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder leiomyosarcoma
+∞
14.7
14
*
WF002
NOMESCO Finland
Radical radiotherapy
160.2
14.6
15
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
12.7
13.7
24
21
A79
ICPC
Malignancy NOS
+∞
13.7
13
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
19.8
13.6
20
11
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
15.1
13.6
22
16
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
13.5
120
630
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
43.0
13.3
16
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.3
13.2
32
50
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
30.5
13.2
17
6
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
12.6
12
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
12.6
12
*
8890/3-C49.4
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.6
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.6
12
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
12.6
12
*
8890/3-C48.0
ICD-O-3
Leiomyosarcoma, NOS, of retroperitoneum
+∞
12.6
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.6
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
12.6
12
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
32.0
11.8
15
5
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
4.7
11.8
42
106
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
45.8
11.0
13
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
29.7
10.9
14
5
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
13.0
10.6
18
15
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.5
10.5
27
46
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
10.5
10
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
10.5
10
*
C49.53
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis leiomyosarcoma
+∞
10.5
10
*
C54.12
ICD-10 Finland
Adenosquamous carcinoma of the endometrium
+∞
10.5
10
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.4
10.0
26
45
TPH07
NOMESCO Finland
Cathetrisation of artery
4.4
9.7
36
94
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
31.6
9.5
12
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
9.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
343
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
8890/3-C55.9
ICD-O-3
Leiomyosarcoma, NOS, of uterus, NOS
+∞
9.4
9
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
9.4
9
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.7
9.4
32
77
WX402
NOMESCO Finland
General anaesthesia
3.5
9.1
45
152
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
19.6
9.0
13
7
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
9.0
49
176
R50.9
ICD-10 Finland
Fever, unspecified
3.4
9.0
45
153
C61
ICD-10 Finland
Malignant neoplasm of prostate
93.5
8.5
9
*
S18
ICPC
Laceration/cut
2.4
8.4
104
607
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
8.4
8
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
8.4
8
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
+∞
8.4
8
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
8.4
8
*
C54.9
ICD-10 Finland
Malignant neoplasm: Corpus uteri, unspecified
+∞
8.4
8
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
8.4
8
*
C49.03
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck Leiomyosarcoma
+∞
8.4
8
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
8.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
8.4
8
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.3
8.0
17
22
ZZA00
NOMESCO Finland
Split skin graft
9.0
8.0
16
19
ZX120
NOMESCO Finland
Intravenous
4.3
7.9
29
75
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.0
7.9
15
16
SPAT1153
SPAT
Removal of sutures
2.4
7.9
83
441
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
5.6
7.8
22
43
JAH00
NOMESCO Finland
Laparotomy
8.5
7.7
16
20
JN3AD
NOMESCO Finland
Abdominal CT examination
4.9
7.5
24
54
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
82.8
7.5
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
82.8
7.5
8
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
7.4
49
201
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
7.4
27
70
C49.83
ICD-10 Finland
Overall malignant tumor of connective tissue and other soft tissue leiomyosarcoma
+∞
7.3
7
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
7.3
7
*
X77
ICPC
Malignant neopl genital female other
+∞
7.3
7
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
7.3
7
*
C54.29
ICD-10 Finland
Unspecified uterine sarcoma
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
1820C
ICD-9 Finland
Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]
+∞
7.3
7
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
16.4
7.3
11
7
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.0
7.1
22
48
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
41.4
6.8
8
*
C03CA01
ATC
furosemide; systemic
2.2
6.8
85
485
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
12.8
6.7
11
9
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
71.8
6.5
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
71.8
6.5
7
*
SPAT1255
SPAT
Intravenous administration of medicine
4.4
6.4
22
54
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
6.4
33
115
JN6AD
NOMESCO Finland
CT of torso and neck
+∞
6.3
6
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
6.3
6
*
D77
ICPC
Malignant digestive neopl other/NOS
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
+∞
6.3
6
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
+∞
6.3
6
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
YJ1CD
NOMESCO Finland
Very extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
6.3
6
*
8890/3-C49.6
ICD-O-3
Leiomyosarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
6.3
6
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
27.5
6.3
8
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.0
6.1
14
21
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
9.0
6.1
12
14
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
6.0
35
132

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
101
54
27.10
134.01
1.4
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
155
609
4.05
33.12
6.0
3.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
165
681
4.00
32.74
3.9
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
75
174
5.35
31.76
1.4
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
208
1037
3.98
30.52
5.9
3.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
62
127
5.84
30.05
2.3
1.5
ug/l
2.4
2.8
0.44
43
102
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
130
528
3.50
25.07
3.6
2.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
227
1312
3.64
24.20
20.0
6.4
e9/l
4.1
4.2
0.41
205
1136
(40768804) Tissue Pathology biopsy report
164
792
3.24
23.40
2.7
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
209
1189
3.27
22.02
8.4
6.0
mmol/l
1.2
1.2
1.81
174
1026
(3024561) Albumin [Mass/volume] in Serum or Plasma
192
1047
3.15
21.66
7.7
3.7
g/l
34.0
35.6
3.27
182
973
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
36
62
6.43
20.59
2.6
2.7
u/ml
0.3
0.4
0.31
20
38
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
194
1090
3.04
20.27
8.0
5.4
mmol/l
1.2
1.2
1.03
183
957
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
47
125
4.25
16.34
7.7
5.9
mmol/l
24.5
25.7
1.19
47
125
(3017181) Myelocytes/100 leukocytes in Blood
57
175
3.76
16.25
3.4
4.5
%
1.6
0.8
1.42
33
36
(3032080) INR in Blood by Coagulation assay
171
987
2.61
15.54
11.4
9.9
inr
1.3
1.3
0.25
50
266
(3033658) Prothrombin time (PT) actual/Normal
112
548
2.62
14.05
6.0
3.1
%
90.5
89.7
0.12
107
535
(3021440) Promyelocytes/100 leukocytes in Blood
51
165
3.50
13.34
3.6
4.7
%
0.3
0.1
1.25
28
31
(3002179) Metamyelocytes/100 leukocytes in Blood
50
164
3.44
12.79
3.5
4.5
%
1.1
0.3
1.96
25
25
(3018418) pH of Serum or Plasma
128
702
2.39
12.25
6.0
3.1
ph
7.4
7.4
0.54
34
108
(3042936) Bacteria identified in Isolate by Culture
79
346
2.71
12.17
2.1
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
46
148
3.47
12.10
1.8
1.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
66
264
2.90
12.05
7.3
8.4
mmol/l
0.6
1.9
2.66
48
214
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
83
380
2.61
11.65
2.0
1.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
64
261
2.82
11.23
7.5
8.6
kpa
15.9
11.6
5.28
59
252
(3015377) Calcium [Moles/volume] in Serum or Plasma
142
838
2.27
11.23
9.3
2.1
mmol/l
2.4
2.4
0.01
133
698
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
251
1895
2.62
10.86
17.9
5.2
u/l
91.0
76.4
5.20
244
1728
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
15
20
7.83
10.65
1.5
1.3
u/ml
3.2
187.7
0.48
15
20
(3007853) Bacteria identified in Skin by Aerobe culture
66
282
2.70
10.56
1.8
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
208
1459
2.26
10.47
6.5
4.4
mmol/l
7.0
6.7
0.96
202
1357
(3031040) Bacteria [#/volume] in Urine by Automated count
226
1642
2.34
10.43
5.9
4.5
e6/l
196.0
3691.6
—
7
25
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
96
496
2.35
10.23
6.0
2.2
mmol/l
2.5
2.4
1.57
88
435
(3025159) Blasts/100 leukocytes in Blood
45
159
3.14
10.14
3.8
4.8
%
0.1
3.1
0.48
25
28
(3000991) Gas panel - Venous blood
48
181
2.95
9.66
9.4
7.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
61
4.37
9.63
1.8
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
102
555
2.24
9.53
17.6
4.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
54
221
2.74
9.34
8.5
9.3
g/l
116.9
122.3
1.32
54
216
(42870588) Differential panel, method unspecified - Blood
127
767
2.10
9.01
6.0
5.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
165
1106
2.04
8.73
6.5
5.6
%
8.7
8.5
0.21
155
1015
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
29
5.76
8.59
1.2
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
160
1067
2.02
8.52
6.4
5.4
%
0.6
0.7
2.02
150
970
(3002030) Lymphocytes/100 leukocytes in Blood
166
1123
2.01
8.47
6.5
5.5
%
22.7
27.8
6.95
154
1026
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
60
273
2.48
8.34
1.8
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
17
34
5.23
8.23
4.2
3.3
%
57.9
57.8
0.01
17
34
(3018095) Leukocytes [#/volume] in Urine
134
847
2.02
8.22
4.1
3.5
e6/l
358.5
114.8
0.46
103
588
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
271
2.45
8.02
1.9
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
127
794
2.01
7.99
2.8
2.1
u/l
55.6
58.8
0.29
122
721
(3026008) Bacteria identified in Urine by Culture
130
820
2.00
7.97
3.8
3.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
162
1105
1.96
7.89
6.4
5.3
%
2.5
2.9
1.93
151
1004
(3002582) Erythrocytes [#/volume] in Urine
117
716
2.01
7.77
3.6
2.9
e6/l
90.3
165.1
0.32
95
541
(3001604) Monocytes [#/volume] in Blood
170
1190
1.93
7.56
5.9
5.1
e9/l
0.6
0.6
0.21
151
1015
(3018010) Neutrophils/100 leukocytes in Blood
162
1117
1.93
7.53
6.0
5.3
%
60.7
57.4
2.41
151
1026
(3030905) Polymorphonuclear cells [#/volume] in Blood
16
33
5.06
7.49
4.1
2.7
e9/l
3.4
4.3
0.63
16
33
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
246
2.44
7.45
6.5
3.1
—
—
—
0
0
(3020891) Body temperature
29
95
3.26
7.37
4.2
4.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
174
1234
1.92
7.37
6.1
5.5
e9/l
0.2
0.2
3.78
156
1074
(3006315) Basophils [#/volume] in Blood
170
1201
1.91
7.24
5.9
5.1
e9/l
0.0
0.0
1.66
153
1023
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
121
766
1.94
7.18
6.7
2.6
u/l
41.4
31.3
0.87
115
727
(3030467) Casts [#/volume] in Urine by Automated count
108
662
1.96
7.01
3.4
2.9
e6/l
0.5
0.5
0.11
85
487
(3003694) ABO and Rh group [Type] in Blood
95
558
2.01
6.96
1.4
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
87
496
2.04
6.92
2.6
2.2
e6/l
7.0
6.0
0.24
76
432
(36304419) Bacteria [Presence] in Urine
104
633
1.96
6.87
3.4
2.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
36
4.63
6.79
1.5
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
169
1218
1.84
6.52
6.1
5.1
e9/l
1.8
1.9
0.25
153
1059
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
18
6.30
6.47
1.6
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
10
7
14.70
6.44
1.9
1.7
—
—
—
0
0
(4281824)
10
15
6.85
6.35
1.1
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
75
417
2.05
6.34
3.0
2.6
e6/l
1.1
1.4
0.71
48
221
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
70
382
2.07
6.21
3.4
2.8
e6/l
3.9
3.3
0.18
42
187
(3026782) Osmolality of Urine
81
471
1.97
6.01
3.0
2.6
mosm/kgh2o
488.4
532.4
0.89
70
393
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
45
3.94
5.89
1.6
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
9
11.43
5.83
2.3
1.3
ug/l
22.9
13.7
—
10
9
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
28
4.80
5.79
1.7
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
17
6.04
5.66
1.9
4.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
36
155
2.49
5.58
3.6
7.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
29
4.63
5.56
1.5
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
26
4.76
5.30
1.6
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
22
5.15
5.30
1.6
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
82
500
1.87
5.21
5.4
4.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
31
129
2.56
5.15
2.2
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
27
4.58
5.08
1.4
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
51
3.47
4.96
1.6
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
32
4.19
4.94
1.5
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
144
1052
1.68
4.82
15.6
8.1
e9/l
0.0
0.0
0.67
122
838
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
32
140
2.43
4.80
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
115
2.58
4.78
9.4
12.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
44
224
2.12
4.64
2.8
3.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
313
1.96
4.59
2.9
2.4
%
21.3
23.4
0.64
48
268
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
49
3.39
4.53
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
9
9.08
4.30
1.1
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
16
52
3.19
4.14
4.3
3.1
kpa
9.1
8.3
0.80
16
52
(3013290) Carbon dioxide [Partial pressure] in Blood
16
52
3.19
4.14
4.3
3.1
kpa
4.7
5.2
1.53
16
52
(3012501) Base excess in Blood by calculation
16
52
3.19
4.14
4.3
3.1
mmol/l
2.4
3.5
0.78
11
35
(40768793) Breast Pathology biopsy report
10
24
4.27
3.91
1.1
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
11
7.43
3.88
1.5
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
67
2.79
3.72
2.5
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
44
245
1.93
3.64
3.5
3.1
mmol/l
2.3
2.5
0.14
36
196
(3010503) CD19 cells [#/volume] in Blood
6
6
10.16
3.51
2.8
1.2
e9/l
0.0
0.2
—
6
6
(3012544) pH of Venous blood
45
256
1.88
3.49
3.4
3.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
10
7.13
3.38
1.6
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
10
7.13
3.38
1.6
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
38
207
1.95
3.35
2.7
2.0
u/l
46.8
35.4
0.35
32
168
(3037467) Urinalysis macro (dipstick) panel - Urine
205
1729
1.53
3.20
5.5
4.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
94
671
1.57
3.19
4.6
3.9
estimate
0.0
0.0
0.00
28
214
(3035350) Ketones [Presence] in Urine by Test strip
156
1243
1.51
3.19
4.1
3.7
estimate
0.0
0.0
0.00
32
218
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
110
817
1.53
3.12
2.9
3.0
ng/l
2467.7
1385.2
1.29
98
685
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
8
7.62
3.06
1.2
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
7
12
5.94
3.03
1.1
1.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
7
12
5.94
3.03
3.3
1.8
nmol/l
5.4
3.3
—
7
12
(3009261) Glucose [Presence] in Urine by Test strip
157
1267
1.48
2.94
4.2
3.7
estimate
0.0
0.0
0.50
30
214
(3021601) Nitrite [Presence] in Urine by Test strip
155
1248
1.48
2.94
5.3
5.1
estimate
0.0
0.0
0.00
31
212
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
89
2.33
2.93
2.6
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
84
596
1.56
2.90
3.0
3.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
13
5.48
2.88
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
9
6.77
2.88
2.8
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
86
616
1.55
2.85
2.0
2.2
mg/l
2.9
3.1
0.30
74
517
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
24
447
0.50
2.80
1.3
1.2
u/ml
24.5
14.1
0.24
13
167
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
500
1.57
2.72
4.0
4.3
ng/l
21.6
224.4
1.65
62
408
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
275
2518
1.74
2.71
30.4
12.7
mg/l
31.0
21.6
4.31
256
1924
(3025941) Bacteria identified in Stool by Culture
24
121
2.06
2.63
1.2
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
37
219
1.78
2.55
2.2
3.9
ng/l
165.9
243.4
0.79
30
201
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
16
4.45
2.49
1.3
1.1
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
13
51
2.62
2.47
1.7
2.1
mg/l
1.7
1.6
0.29
13
46
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
33
191
1.81
2.45
4.1
1.8
ml/min/173m2
60.2
65.5
0.36
17
69
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
131
1048
1.43
2.44
4.0
3.8
ng/l
28.0
70.0
0.70
105
749
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
243
2635
0.66
2.40
4.6
5.3
mmol/l
2.6
2.7
0.95
217
2414
(40768443) Skin Pathology biopsy report
20
99
2.09
2.31
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
9
5.62
2.22
1.0
1.1
—
1.0
—
0
9
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
24
3.39
2.19
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
703
0.64
2.17
1.5
1.6
mmol/l
1.4
1.3
0.19
39
593
(3044889) 12 lead EKG panel
206
1808
1.41
2.15
4.5
3.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
25
3.26
2.11
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
25
3.26
2.11
1.3
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
62
2.32
2.11
1.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
26
3.13
2.02
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
26
3.13
2.02
1.3
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
26
3.13
2.02
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
2562
0.69
1.98
4.1
4.7
mmol/l
1.5
1.5
1.32
210
2348
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
51
2.41
1.97
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
85
2.06
1.94
2.6
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
44
295
1.57
1.93
1.3
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
240
2585
0.70
1.91
4.1
4.7
mmol/l
4.5
4.7
1.66
217
2377
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
59
2.26
1.87
1.3
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
67
878
0.70
1.84
3.5
3.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
12
4.22
1.83
1.6
1.2
umol/l
38.8
19.5
—
5
12
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
23
3.09
1.81
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
203
1.64
1.76
1.8
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
25
148
1.75
1.76
2.6
2.2
g/l
8.5
10.9
3.90
25
137
(3022806) Fractional oxyhemoglobin in Capillary blood
8
30
2.71
1.73
1.9
1.7
%
84.4
90.0
—
8
30
(3022217) INR in Platelet poor plasma by Coagulation assay
51
363
1.48
1.72
24.2
24.2
inr
1.7
1.3
—
7
55
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
182
1598
1.33
1.70
4.3
2.9
u/l
67.4
45.7
2.15
173
1473
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
466
0.63
1.68
1.3
1.3
iu/ml
16.5
35.2
—
10
143
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
31
2.62
1.67
1.6
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
207
1.61
1.64
2.2
2.2
e9/l
59.2
70.3
0.98
25
165
(3023430) Cat dander IgE Ab [Units/volume] in Serum
5
14
3.61
1.62
1.0
1.1
—
2.5
—
0
5
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
70
2.05
1.62
2.0
3.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
3.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
260
1.53
1.55
1.7
2.6
ug/l
10.7
7.5
0.17
29
222
(3028026) IgM [Mass/volume] in Serum or Plasma
21
123
1.76
1.55
2.0
1.3
g/l
0.8
1.1
1.50
21
114
(1616796) Gas panel - Central venous blood
10
44
2.31
1.55
2.8
3.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
43
0.00
1.53
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
21
2.89
1.51
1.2
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
75
592
1.35
1.42
4.3
3.8
kg/l
1.0
1.0
—
7
86
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
256
2392
1.38
1.41
31.6
11.4
ml/min/173m2
77.2
77.1
0.02
239
1905
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
116
976
1.30
1.41
4.8
3.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
23
2.64
1.37
2.0
2.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
17
2.97
1.36
1.2
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
17
2.97
1.36
1.2
1.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
17
2.97
1.36
1.0
1.5
%
6.9
11.9
—
5
17
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
230
2460
0.76
1.35
6.2
6.0
mmol/mol
42.6
40.2
2.19
205
2284
(40761536) Microorganisms panel - Urine sediment
29
194
1.55
1.32
4.6
3.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
24
2.53
1.31
1.2
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
34
2.39
1.30
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
35
246
1.48
1.28
5.3
4.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
25
2.43
1.25
2.7
2.0
pg
34.2
32.1
—
6
25
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
25
2.43
1.25
1.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
19
2.66
1.22
1.2
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
19
2.66
1.22
1.0
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
125
1.64
1.21
1.7
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
50
2.03
1.17
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
50
2.03
1.17
1.6
1.3
—
—
—
0
0
(4268621)
5
20
2.52
1.15
2.2
1.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
194
0.55
1.13
2.1
1.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
30
2.36
1.13
1.3
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
7
31
2.29
1.11
1.3
1.4
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
7
31
2.29
1.11
14.7
2.6
mmol/l
8.2
6.7
—
7
22
(3013512) EKG study
93
783
1.27
1.10
4.9
3.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.2
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
68
552
1.30
1.07
1.9
1.7
mg/l
2.0
1.0
1.70
53
424
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.29
1.04
1.2
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
99
846
1.25
1.02
2.6
2.9
mmol/l
7.2
7.1
0.05
79
699
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
157
0.56
1.01
1.2
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
45
348
1.34
0.99
6.7
7.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
23
2.19
0.98
2.4
2.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
15
93
1.64
0.95
4.9
2.1
ug/l
512.4
740.3
0.19
15
86
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
37
1.91
0.94
1.1
1.2
—
—
—
0
0
(4306422)
6
27
2.25
0.94
2.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
68
563
1.27
0.92
1.6
1.7
pmol/l
496.7
453.1
0.29
50
460
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
19
127
1.53
0.91
3.0
2.0
%
1.2
1.1
0.21
19
127
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
42
1.93
0.89
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
94
811
1.23
0.88
2.7
3.0
mg/l
651.6
292.8
0.24
61
495
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
32
239
1.38
0.88
1.8
1.5
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
30
2.02
0.87
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
234
2459
0.81
0.85
3.8
4.3
mmol/l
1.3
1.3
0.75
205
2235
(1761482) Bacteria [#/volume] in Urine by Culture
13
81
1.63
0.82
5.6
4.9
—
—
—
0
0
(3000492) Spirometry study
14
211
0.65
0.81
1.6
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
13
199
0.64
0.81
1.6
1.9
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
133
0.59
0.75
1.4
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
38
1.86
0.74
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
38
1.86
0.74
1.6
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
25
2.02
0.73
1.4
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
60
1.69
0.73
3.6
2.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
40
1.77
0.71
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
40
1.77
0.71
2.4
2.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
13
85
1.55
0.70
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
13
85
1.55
0.70
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
27
1.87
0.68
1.2
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
27
1.87
0.68
1.0
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
179
0.66
0.68
1.5
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
246
2557
0.82
0.68
4.5
4.8
mmol/l
6.2
6.0
0.81
220
2326
(3019309) Folate [Moles/volume] in Red Blood Cells
45
541
0.80
0.66
1.9
1.8
nmol/l
1640.1
1186.8
1.65
30
401
(21494755) Public health laboratory ask at order entry panel
13
188
0.68
0.64
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
13
87
1.52
0.64
1.1
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
30
1.68
0.61
1.0
1.5
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
11
72
1.55
0.60
1.4
1.9
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
22
0.00
0.59
0.0
1.0
—
41.9
—
0
13
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
289.7
—
0
13
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
514.8
—
0
13
(3021788) Differential panel - Synovial fluid
8
53
1.52
0.59
1.5
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
271
2632
1.22
0.54
26.8
12.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
39
1.55
0.53
4.7
1.9
%
63.5
61.0
—
6
39
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
6
97
0.61
0.53
1.0
2.3
u/l
30.5
42.0
—
6
87
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
97
1067
0.87
0.53
2.3
2.3
nmol/l
74.3
79.4
1.09
85
929
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
14
100
1.42
0.52
4.6
4.1
mmol/l
23.8
25.1
0.62
14
94
(3001122) Ferritin [Mass/volume] in Serum or Plasma
113
1036
1.14
0.51
2.7
2.8
ug/l
193.4
105.6
2.57
104
947
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
76
1.46
0.48
1.2
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
73
651
1.16
0.48
2.8
2.3
umol/l
333.2
10617.9
4.04
64
559
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
82
0.60
0.46
2.2
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
82
0.60
0.46
1.6
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
85
0.58
0.46
1.2
1.5
g/l
1.2
1.2
—
5
80
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
43
369
1.19
0.45
1.3
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
139
1.31
0.44
4.3
4.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
56
1.44
0.43
1.4
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
32
1.57
0.42
2.0
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
114
1.33
0.41
4.5
3.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
0.9
—
0
15
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
15
0.00
0.41
0.0
1.7
—
3.4
—
0
9
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
259
0.80
0.41
1.9
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
17
0.00
0.41
0.0
2.4
—
13.8
—
0
17
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
480
1.15
0.38
5.5
3.8
%
19.3
25.0
2.97
31
236
(3052851) Hemolysis interference index of Serum or Plasma
9
69
1.31
0.37
3.3
3.7
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
69
1.31
0.37
5.0
1.4
—
1.2
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
10
135
0.73
0.37
1.6
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
49
434
1.15
0.36
1.7
1.3
g/l
2.5
2.6
0.11
29
254
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
76
0.65
0.36
4.0
1.3
g/l
0.2
0.1
—
5
71
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
210
2026
1.11
0.36
4.6
4.0
pmol/l
15.0
14.9
0.27
195
1822
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
80
0.62
0.35
2.0
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
32
371
0.85
0.35
1.4
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
43
1.40
0.35
2.5
2.1
mmol/l
3.9
4.1
—
6
43
(3035285) Chloride [Moles/volume] in Venous blood
6
43
1.40
0.35
2.5
2.1
mmol/l
103.0
105.4
—
6
43
(3044941) Cell count panel - Synovial fluid
6
43
1.40
0.35
1.5
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
74
677
1.12
0.34
5.0
3.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
349
0.84
0.34
4.0
4.9
%
31.9
32.8
0.19
22
221
(3011288) Drugs identified in Urine by Screen method
6
45
1.34
0.34
1.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
72
659
1.12
0.33
1.4
1.5
nmol/l
23.2
21.2
0.42
60
565
(40760888) Immunoglobulin light chains.free panel - Serum
6
47
1.28
0.32
3.7
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
344
1.15
0.31
3.3
2.7
ug/l
0.7
0.8
0.21
30
230
(3020682) Albumin/Creatinine [Ratio] in Urine
92
857
1.10
0.31
3.7
3.7
mg/mmol
6.4
7.3
0.15
60
521
(3015235) Bicarbonate [Moles/volume] in Capillary blood
7
56
1.26
0.29
2.6
2.6
mmol/l
25.4
25.3
—
7
47
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
277
2725
1.14
0.28
21.3
8.9
u/l
27.3
24.6
2.16
272
2599
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
71
0.70
0.26
4.0
1.3
g/l
0.0
0.0
—
5
66
(3004716) Salmonella sp identified in Stool by Organism specific culture
15
123
1.23
0.26
1.1
1.3
—
—
—
0
0
(4034850)
12
96
1.26
0.25
9.6
6.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
77
1.17
0.24
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
169
0.82
0.24
2.9
2.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
181
1.17
0.23
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
41
1.22
0.22
1.0
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
42
1.19
0.21
2.6
2.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
11
0.00
0.21
0.0
10.5
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
11
0.00
0.21
0.0
7.1
—
25.5
—
0
11
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.4
—
13.8
—
0
10
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
8.4
—
0.6
—
0
12
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
43
1.17
0.21
2.8
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
13
0.00
0.21
0.0
3.5
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.0
—
0.8
—
0
9
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
90
1.23
0.19
2.5
1.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
200
1953
1.07
0.19
3.6
4.1
mm/h
17.2
12.3
2.38
175
1781
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
53
1.13
0.19
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
119
1.18
0.18
1.1
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
61
1.15
0.17
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
62
1.13
0.17
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
62
1.13
0.17
1.3
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
62
1.13
0.17
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
92
1.20
0.16
1.6
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
100
0.79
0.14
2.9
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
55
522
1.07
0.13
1.2
1.3
u/ml
0.9
1.6
0.80
16
150
(4010399)
18
198
0.90
0.11
1.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
238
2407
0.95
0.11
5.2
4.9
mu/l
2.0
2.4
0.34
217
2177
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
139
1420
0.96
0.10
2.6
2.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14
125
1.13
0.10
3.6
3.4
pmol/l
4.3
4.5
0.64
14
109
(3009542) Hematocrit [Volume Fraction] of Blood
223
2257
0.96
0.10
30.6
14.1
%
37.3
39.7
3.44
149
1539
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
iu/l
51.5
26.9
—
6
44
(3014051) Protein [Presence] in Urine by Test strip
6
55
1.09
0.09
1.5
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
5
62
0.80
0.08
1.0
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
32
303
1.06
0.08
1.7
1.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
7
66
1.06
0.08
1.0
1.2
mmol/l
4.5
3.9
—
7
60
(1002224) Polysomnography panel
8
93
0.86
0.07
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
109
1111
0.97
0.06
1.9
2.0
pmol/l
89.4
96.9
0.85
57
532
(3022145) Colonoscopy Study observation
24
254
0.94
0.06
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
168
1.08
0.06
2.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
178
1.07
0.06
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
151
1.06
0.03
2.3
2.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
10
93
1.08
0.02
1.5
2.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
15
149
1.01
0.00
1.1
1.2
u/ml
188.9
190.9
0.01
15
138
(40768797) Stomach Pathology biopsy report
35
355
0.98
0.00
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
74
0.94
0.00
1.0
1.3
mg/l
540.3
487.6
—
7
66
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
55
0.91
0.00
1.4
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
68
0.88
0.00
2.0
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
91.7
—
0
8
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
60
1.00
0.00
1.3
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
7
0.00
0.00
0.0
9.9
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.5
—
49.3
—
0
6
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
61
0.98
0.00
1.2
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.6
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
56
0.89
0.00
1.8
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
5.8
—
0
6
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
56
0.89
0.00
1.0
1.1
—
13.1
—
0
8
(3016330) Potassium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_LEIOMYOSARCOMA_EXALLC – Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).